However, some research indicates that YTHDF2 suppresses tumor progression in Hepatocellular carcinomas and osteosarcomas (Hou et al., 2019; Zhong et al., 2019; Yang et al., 2020). The gene discussed is YTHDF2; the disease is neoplasm.